原著論文


【2020】


184.Tomoya Tachi, Yoshihiro Noguchi, Hitomi Teramachi, Developing and Verifying the Efficacy of “Educational Program for Promoting Appropriate Self-medication via Pharmacies and Pharmacists”: A Randomized Controlled Trial, Biol. Pharm. Bull.,43, 77-86, 2020.

185.Tomoya Tachi, Yumi Toda, Takayuki Seko, Yoshihiro Noguchi, Hitomi Teramachi, Impact of infection control measures on the related costs and the amount of broad-spectrum antimicrobial agents used in a hospital: a time-series analysis, Int. J. Health Plann. Manage., 35, e133-e141. doi: 10.1002/hpm.2944, 2020.

186.Yoshihiro Noguchi, Hiroki Esaki, Azusa Murayama, Mayuko Sugioka, Aisa Koyama, Tomoya Tachi, Hitomi Teramachi, Association between Dipeptidyl peptidase-4 inhibitor and aspiration pneumonia: disproportionality analysis using the spontaneous reporting system in Japan, Eur. J. Clin. Pharmacol., 76, 299-304, 2020.

187.森美穂,島内あかり,矢島聖子,西尾裕斗,玉木啓文,堺千紘,長内理大,伊野陽子,寺町ひとみ,中村光浩,井口和弘, 機能性表示食品の包装の情報記載状況に関する調査,YAKUGAKU ZASSHI,140, 443-448, 2020.

188.Michio Kimura, Eiseki Usami, Hitomi Teramachi, Tomoaki Yoshimura, A comparative study of nivolumab and axitinib in terms of overall survival, treatment continuation, and cost for patients with metastatic renal cell carcinoma, Mol. Clin. Oncol., 12, 284-289, 2020.

189.Michio Kimura, Eiseki Usami, Hitomi Teramachi, Tomoaki Yoshimura, Risk Benefit of FOLFIRI Plus Ramucirumab as Third-line and Later-line Treatment of Metastatic Colorectal Cancer, Anticancer Res., 40, 1605-1611, 2020.

190.Eiseki Usami, Michio Kimura, Shoya Takenaka, Tomoe Kanda, Hitomi Teramachi, Tomoaki Yoshimura, Continuity and efficacy of real-world use of azacitidine, Pharmazie, 75, 154-158, 2020.

191.Yoshihiro Noguchi, Tomoya Tachi, Hitomi Teramachi, Comparison of Signal Detection Algorithms Based on Frequency Statistical Model for Drug-Drug Interaction Using Spontaneous Reporting Systems, Pharm. Res., 37, 86. doi: 10.1007/s11095-020-02801-3, 2020.